Hims argued that compounded GLP-1 drugs serve an essential role in addressing unmet demand, claiming that nearly 30% of Weight Loss customers who had been prescribed a branded GLP-1 product in the past were unable to fill it because the medication was not available at their pharmacy. The Alliance for Pharmacy Compounding, another industry group, also contends that the shortage is ongoing, sharing screenshots from pharmacies showing limitations on their ability to order tirzepatide
This is not a gentle increase in appetite
References Maier, C., Hartung, N., de Wiljes, J., Kloft, C., & Huisinga, W
Firms submitting through this site for the first time will be asked to register in DSIP
That increases resistant starch content and is a simple swap with measurable effects on fermentation
Eylea (Aflibercept) Regeneron LOE 2025-2027 Regenerons Eylea, the vascular endothelial growth factor (VEGF) trap for wet AMD and diabetic macular edema, generated approximately $5.9 billion in the U.S